Insight Pharmaceuticals Appoints New Vice President of Sales

Company welcomes Jeff Vernimb, previously of Dynova Laboratories

LANGHORNE, Pa.--(BUSINESS WIRE)-- Insight Pharmaceuticals, provider of quality consumer and personal care products, today announced that Jeff Vernimb will join the company as Vice President of Sales. With over 25 years experience in consumer product sales and marketing, Mr. Vernimb brings a high level of expertise to the Insight Pharmaceuticals team. Vernimb will lead the Insight Pharmaceuticals sales team as well has have full responsibility for the creation and implementation of our trade marketing strategy. Vernimb will report to Gary R. Downing, CEO at Insight Pharmaceuticals.

“Mr. Vernimb brings with him over 25 years experience in consumer product sales and marketing,” says Gary R. Downing, CEO at Insight Pharmaceuticals. “We are confident that his strategic planning skills, coupled with his intricate understanding of our industry, will help our company meet the aggressive goals we have set for sales and growth. We couldn’t be happier to have him on board.”

Prior to his position with Insight Pharmaceuticals, Vernimb was the Vice President of Marketing and Sales at Dynova Laboratories, a marketer of natural healthcare products. In addition to his position at Dynova, Mr. Vernimb has held senior positions at leading Fortune 200 healthcare companies including Cardinal Health, where he was Global Vice President of Marketing for the oral drug delivery technologies and contract manufacturing businesses; Novartis Consumer Health, where he was Vice-President of Marketing for the $700 million U.S. business and Pfizer/Warner Lambert where he spent 11 years in a number of marketing and customer marketing roles. He began his career in Sales with The Mennen Company.

About Insight Pharmaceuticals:

Insight Pharmaceuticals is a consumer products company whose strategy is to generate growth by acquiring brands with solid consumer equity that can be further developed through their merchandising and marketing expertise. The company strengthens its portfolio of brands by employing a variety of strategies, all with an in-depth understanding of the heritage of the brand and the needs of the consumer. Additional information about Insight Pharmaceuticals can be found at www.InsightPharma.com.



CONTACT:

Press contact:
Gregory FCA
Robyn Ungar
Associate Vice President
610-228-2131
[email protected]
or
Company contact:
Insight Pharmaceuticals Corp.
Jennifer Moyer
Vice President of Marketing
267-852-0505
[email protected]

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:   Health  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.